Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors

Anesthesiology

Volumn 86, Issue 4, 1997, Pages 903-917

  Orser, Beverley A ^a,b   Pennefather, Peter S ^b   MacDonald, John F ^c  

^a Departments of Anaesthesia and Physiology   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Department of Physiology ^*

Author keywords

Anesthetic; Blockade; Ion channel; Ketamine; N methyl D aspartate

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANESTHESIA; ANIMAL CELL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DRUG MECHANISM; FETUS; HIPPOCAMPUS; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RECEPTOR BLOCKING;

ANESTHETICS, DISSOCIATIVE; ANIMALS; BINDING SITES; CELLS, CULTURED; HIPPOCAMPUS; ION CHANNELS; KETAMINE; MICE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030907708     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199704000-00021     Document Type: Article

References (66)

1. Mon H, Mishina M: Review: Neurotransmitter receptors VIII. Structure and function of the NMDA receptor channel. Neuropharmacology 1995; 34:219-37
2. Johnson JW, Ascher P: Glycine potentiates the NMDA response in cultured mouse brain neurones. Nature 1987; 325:522-5
3. Legcndre P, Rosenmund C, Westbrook GL: Inactivation of NMDA channels in cultured hippocampal neurons by intracellular calcium. J Neurosci 1993; 13:674-84
4. Turecck R, Vylicky L, Vlachova V, Vylicky L, G-protein modulation of glycine-resistant N.MDA receptor desensitization in rat cultured hippocampal neurons. EurJ Neurosci 1995; 7:1826-30
5. McBain CJ, Mayer ML: N-methyl-D-aspartic acid receptor structure and function. Physiol Rev 1994; 74:723-60
6. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurological disorders. N EngI J Med 1994; 330:613-22
7. MacDonald JF, Bartlett MC, Mody I, Pahapill P, Reynolds JN, Salter MW, Schneiderman JH, Pennefather PS: Action of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J Physiol 1991; 432:483-508
8. Mayer ML, Westbrook GL, Vyklicky L: Sites of antagonist action on N-methyl-D-aspartate acid receptors studied using fluctuation analysis and a rapid perfusion technique. J Neurophysiol 1988; 60:645-63
9. Irfune M, Shimizu, Nomoto M, Fukuda T: Ketamine-induced anesthesia involves the N-methyl-D-aspartate-channel complex in mice. Brain Res 1992; 596:1-9
10. Reich D, Silvay G: Ketamine: An update on the first twentyfive years of clinical experience. Can J Anaesth 1989; 36:186-97
11. Honey CR, Miljkovic Z, MacDonald JF: Ketamine and phencyclidine causes a voltage-dependent block of responses to L-aspartic acid. Neurosci Lett 1985; 61:135-9
12. MacDonald JF, Miljkovic Z, Pennefather P: Use-dependent block of excitatory amino acid currents in cultured neurones by ketamine. J Neurosci 1987; 58:251-66
13. Huettner J, Iiean DP: Block of N-methyl-D-asparate-activated current by the anticonvulsant MK-801: Selective binding to open channels. Proc Natl Acad Sei USA 1988; 85:1301-11
14. Anis NS, Berry SC, Burton NR, Lodge D: The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammaliari neurons by N-methyl-aspartate. Br J Pharmacol 1983; 79:565-75
15. Parsons CG, Gruner R, Rozental J, MillarJ, Lodge D: Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (l-amino-3,5-dimethyladamantan). Neuropharmacology 1993; 32:1337-50
16. Pennefather P, Quastel DMJ: Modification of dose-response curves by effector blockade and uncompetitive antagonism. Mol Pharmacol 1992; 22:369-80
17. Ramoa AS, Albuquerque EX: Phencyclidine and some of its analogues have distinct effects on NMDA receptors of rat hippocampal neurons. FEES Lett 1988; 235:156-62
18. Adams PR: Drug blockade of open end-plate channels. J Physiol 1976; 260:531-52
19. MacDonald JF, Novak LM: Mechanisms of blockade of excitatory amino acid receptors channels. Trends Pharmacol Sei 1990; 11:167-72
20. Hille B: Local anaesthetics: Hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 1977; 69:497-515
21. Ashford MLJ, Boden P, Ramsey RL, Usherwood PNR: Enhancement of desensitization of quisqualate-type glutamate receptors by the dissociative anaesthetic ketamine. J Exp Biol 1989; 141:73-86
22. Aguayo LG, Witkop B, Albuquerque EX: Voltage- and timedependent effects of phencyclidines on the endplate current arise from open and closed channel blockade. Proc Natl Acad Sei USA 1986; 83:3523-7
23. Wachtel RE, Wegrzynowicz ES: Kinetics of nicotinic acetylcholine ion channel in the presence of intravenous anaesthetics and induction agents. Br J Pharmacol 1992; 106:623-7
24. Ferrer-Montiel AV, Sun W, Montai M: Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine. Proc Natl Acad Sei USA 1995; 92:8021-5
25. MacDonald JF, Mody I, Salter MW: Regulation of NMDA receptors revealed by intracellular dialysis. J Physiol 1986; 414:17-23
26. Tong G, Jahr C: Regulation of glycine-insensitive desensitization of the NMDA receptor in outside-out patches. J Neurophysiol 1994; 72:754-61
27. Colquhoun D, Sigworth FJ: Fitting and statistical analysts of single-channel records, Single-channel Recording. Edited by Sackmann B, Neher E. New York, Plenum Press, 1995, pp 483-587
28. Hawkes AG, Jalali A, Colquhoun D: Asymptotic distributions of the apparent open times and shut times in a single channel record allowing for omission of brief events. Phil Trans R Soc Lond [Diol] 1992; 337:383-404
29. Hille B: Ionic channels of excitable membranes. Sunderland MA., Sinauer Associates, 1992, pp 390-422
30. Zeilhofer HU, Swandulla D, Geisslinger G, Brune K: Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. EurJ Pharmacol 1992; 213:155-8
31. White PF, Ham J, Way WL, Trevor AJ: Pharmacology of ketamine isomers in surgical patients. ANESTHESIOLOGY 1980; 52:231-9
32. 2+-free solutions. Neuron 1992; 8:181-7
33. Parsons GC, Quack G, Bresink I, Baran L, Przeganlinski E, Kostowski W, Krzascik P, Hartmann S, Danysz W: Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 1995; 34:1239-58
34. Cohen ML, Trevor AJ: On the cerebral accumulation of ketamine and the relationship between metabolism of the drug and its pharmacological effects. J Pharmacol Exp Ther 1974; 189:351-8
35. Covarnibias M, Steinbach JH: Excision of membrane patches reduces the mean open time of nicotinic acetylcholine receptors. Pflugers Arch 1990; 416:385-92
36. McLaron JG, Sawyer D: Dependence of single channel properties of the N-methyl-D-asparate ion channel on sterioisomer agonist. Exp Brain Res 1993; 95:8- 14
37. McLaron JG, Curry K: Single channel properties of the Nmethyl-D-aspartate receptor channel using NMDA and NMDA agonists. Exp Brain Res 1990; 82:82-8
38. Lima-Landman MTR, Albuquerque EX: Ethanol potentiates and block NMDA-activated single-channel currents in rat hippocampal pyramidal cells. FEES Lett 1989; 247:61-7
39. Parsons CG, Zong X, Lux HD: Whole cell and single channel analysis of the kinetics of glycine-sensitive N-methyl-D-aspartate receptor desensitization. BrJ Pharmacol 1993; 109:213-21
40. Stern P, Cik M, Colquhoun D, Stephenson FA: Single channel properties of cloned NMDA receptors in human cell line: Comparison with results from Xcnopus oocytes. J Physiol 1994; 476:391 -7
41. Gibb AJ, Colqunoun D: Activation of N-methyl-D-aspartate receptors by L-glutamate in cells dissociated from adult rat hippocampus. J Physiol 1992; 456:143-79
42. Benveniste M, Clements J, Vyklicky L, Mayer ML: A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurons. J Physiol 1990; 428:333-7
43. Lin F, Stevens CF: A quantitative description of NMDA receptor-channel kinetic behavior. J Neurosci 1994; 14:2153-60
44. Colquhoun D, Hawkes AG: Desensitization of N-methyl-Daspartate receptors: A problem of interpretation. Proc Natl Acad USA 1995; 92:10327-9
45. Zukin SR, Javitt DC: Phencyclidine receptor binding as a probe of NMDA receptor functioning: Implications for drug abuse research. N1DA Res Monogr 1993; 133:1-12
46. Javitt DC, Zukin SR: Biexponential kinetics of [3]MK-801 binding: Evidence for access to closed and open N-methyl-D-aspartate receptor channels. Mol Pharmacol 1989; 35:387-93
47. Javitt DC, Frusciante J, Zukin SR: Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation. Mol Pharmacol 1990; 37:603-7
48. Scheller M, Bufler J, Schneck HJ, Franke C, Kochs E: Ketamine and its stereoisomers block the nicotinic acetylcholine receptor of mouse myotubules. Anesth Analag 1996; 82:5396
49. Wachtel RE: Ketamine decreases the open time of single-channel currents activated by acetylcholine. ANESTIIESIOLOGY 1988; 68:563-70
50. Heidmann T, Oswald RE, Changeux JP: Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from Torpedo marmorata. Biochemistry 1983; 22:3112-27
51. Forman SA, Miller K: Molecular sites of anesthetic action in postsynaptic nicotinic membranes. Trends Pharmacol Sei 1989; 10:447-52
52. Hertz JM, Johnson DA, Taylor P: Distance between the agonist and noncompetitive inhibitor sites on the nicotinic acetylcholine receptor. J Biochem Chem 1989; 264:12439-48
53. Yamakura T, Mori H, Masaki H, Shimoji K, Mishina M: Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. NeuroReport 1993; 4:687-90
54. 2+-block site of the NMDA receptor channel. Nature 1992; 358:673-5
55. Lee-Son S, Wang GK, Concus A, Crill E, Strichartz G: Stereose-lective inhibition of neuronal sodium channels by local anesthetics: Evidence for two sites of action? AMESTHESIOLOGY 1992; 77:324-35
56. Butterworth JF, Strichartz GR: Molecular mechanisms of local anesthetics: A review. ANESTIIESIOLOGY 1990; 72:711-34
57. Johnson KM, Jones SM: Neuropharmacology of phencyclidine: Basic mechanisms and therapeutic potential. Ann Rev Pharmacol Toxicol 1990; 30:707-50
58. Hartig P, Valtysson J, Lindner K-J, Kristensen J, Karlsten R, Gustafsson LL, Persson J, Svensson JO, Oye I, Antoni G, Westerberg G, Langstrom B: Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers. Clinical Pharmacol Ther 1995; 58:165-73
59. White PF, Ham J, Way WL, Trevor AJ: Pharmacology of ketamine isomere in surgical patients. ANESTHESIOLOGY 1980; 52:231-9
60. Pedraz JL, Lanao JM, Dominguez-Gil: Interspecies pharmacokinetics of ketamine, Status of Ketamine in Anesthesiology. Edited by Domino EF. Ann Arbor, NPP Books, 1990, pp 285-95
61. Dayton PG, Stiller RL, Cook DR, Perel JM: The binding of ketamine to plasma proteins: Emphasis on human plasma. Eur J Clin Pharmacol 1983; 24:825-31
62. Wood M: Plasma binding and limitation of drug access to site of action. ANESTIIESIOLOGY 1991; 75:721-3
63. Cohen ML, Chan SL, Way WL, Trevor AJ: Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. ANESTIIESIOLOGY 1973; 39:370-6
64. Kronhuber J, Quack G, Danysz W, Jellinger K, Danielczyk W, Gsell W, Riederer P: Therapeutic brain concentration of the NMDA receptor antagonist amantadine. Neuropharmacology 1995; 34:713-21
65. Kronhuber J, Quack G: Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantime in man. Neurosci Lett; 195:137-9
66. Fletcher JE, MacDonald JF: Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. EurJ Pharmacol 1993; 235:291-5